Adualys Therapeutics AG, c/o Ganda Business Solutions AG
1-10 employees
Biotechnology Research
Adualys is building next-generation dual-payload antibody-drug conjugates (ADCs) to address cancers that current therapies cannot effectively treat. The company develops novel, bi…
Read more
About us
Adualys is building next-generation dual-payload antibody-drug conjugates (ADCs) to address cancers that current therapies cannot effectively treat. The company develops novel, biology-driven ADCs designed to overcome treatment resistance and deliver deeper and more durable responses in solid tumors.
WE HIRE WITH
- Terms & conditions
- Privacy policy
- Report issue